Tumour necrosis factor-α increases the sensitivity of human immunodeficiency virus (HIV)-infected monocytic U937 cells to the complement-dependent cytotoxicity of sera from HIV type 1-infected individuals; role of the gp120 protein

References

1. Barre-Sinoussi F, Chermann J, Rey F, Nugeyre MT, Chamaret S, Gruest J, Axier-Blin C, Vezinet-Brun F, Rouzioux C, Rosenbaum W, Montagnier J. 1983; Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871
   [Google Scholar]
2. Benedetto A, Elia G, Sala A, Belardelli F. 1989; Hyposialylation of high-molecular-weight membrane glycoproteins parallels the loss of metastatic potential in wheat-germ agglutinin-resistant Friend leukemia cells. International Journal of Cancer 43:126–133
   [Google Scholar]
3. Beutler B, Cerami A. 1987; Cachectin: more than a tumor necrosis factor. New England Journal of Medicine 316:379–385
   [Google Scholar]
4. Bolognesi DP. 1991; Vaccines against acquired immunodeficiency syndrome (AIDS). In The Human Retroviruses pp. 389–405Edited by Gallo RC, Jay G. San Diego: Academic Press;
   [Google Scholar]
5. Gazitt Y, Friend C. 1981; Early and late changes in the glycoproteins of Friend erythroleukemia cells induced to differentiate. Cancer Research 41:1064–1069
   [Google Scholar]
6. Hoffmann GW, Kion TA, Grant MD. 1991; An idiotypic network model of AIDS immunopathogenesis. Proceedings of the National Academy of Sciences, U.S.A. 88:3060–3064
   [Google Scholar]
7. Kloster BE, Tomar RM, Spira TM. 1984; Lymphocytotoxic antibodies in the acquired immune deficiency syndrome (AIDS). Clinical Immunology and Immunopathology 30:330–335
   [Google Scholar]
8. Locardi C, Petrini C, Boccoli G, Testa U, Dieffebanch C, Butto S, Belardelli F. 1990; Increased HIV-expression in chronically infected U937 cells upon in vitro differentiation by hydroxy vitamin D3. Journal of Virology 64:5875–5882
   [Google Scholar]
9. Meltzer MS, Nakamura M, Hansen BD, Turpin JA, Kalter DC, Gendelman HE. 1990; Macrophages as susceptible targets for HIV-infection, persistent viral reservoirs in tissue and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Research and Human Retroviruses 6:967–971
   [Google Scholar]
10. Merill JE, Konayagi Y, Chen ISY. 1989; Interleukin-1 and tumor necrosis factor can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. Journal of Virology 63:4404–4408
    [Google Scholar]
11. Nabel G, Baltimore D. 1987; An inducible transcription factor activates expression of human immune deficiency virus in T-cells. Nature, London 326:711–713
    [Google Scholar]
12. Popovic M, Sarngadharan MG, Read E, Gallo RC. 1984; Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-αIDS. Science 224:479–500
    [Google Scholar]
13. Reddy MM, Sorrel SJ, Lange M, Lange M, Grieco MH. 1988; Tumor necrosis factor and HIV p24 antigen levels in serum of HIV-infected populations. Journal of AIDS 1:436–440
    [Google Scholar]
14. Rosenberg ZF, Fauci AS. 1989; Induction and expression of HIV in latently or chronically infected cells. AIDS Research and Human Retroviruses 5:1–4
    [Google Scholar]
15. Stricker RB, McHugh TM, Moody DJ, Marrow WJ. W, Stites DP, Shuman MA, Levy JA. 1987; An AIDS-related cytotoxic antibody reacts with a specific antigen on stimulated CD4⁺ T cells. Nature, London 327:710–713
    [Google Scholar]
16. Sundstrom C, Nilsson K. 1976; Establishment and characterization of a human histiocytic lymphoma cell line (U937). International Journal of Cancer 17:565–577
    [Google Scholar]
17. Szabo B, Toth FD, Vaczi L, Rethy A, Kiss A, Rak K. 1983; Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukemias and preleukemic disorders. Neoplasma 30:129–135
    [Google Scholar]
18. Szabo B, Toth FD, Kiss J, Horvath A, Banhegyi D, Hollan SR. 1992; Prelevance and specificity of lymphocytotoxic antibodies in different stages of HIV infection. Acta virologica 36:392–400
    [Google Scholar]
19. Toshifumi M, Nobuyuki K, Naoki Y. 1991; Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?. AIDS 5:1405–1417
    [Google Scholar]
20. Toth FD, Kiss J, Szabo B, Fust G, Ujhelyi E, Hollan SR, Vaczi L. 1989; Complement-dependent cytotoxicity of antibodies reactive with HIV-induced cell surface antigens in HIV-carrying haemophiliacs. Acta virologica 33:521–526
    [Google Scholar]
21. Towbin H, Staehelin T, Gordon F. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A. 76:4350–4354
    [Google Scholar]
22. VanHinsberg VWM, Van den Berg EA, Fiers W, Dooijewaard G. 1990; Tumor necrosis factors induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 75:1991–1998
    [Google Scholar]